-
Tavapadon (developmental code
names CVL-751, PF-06649751) is a
dopamine receptor agonist which is
under development for the
treatment of Parkinson's disease...
-
Cerevel drugs and
treatments at
varying stages of
development include:
Tavapadon (Parkinson's)
Emraclidine (Schizophrenia, Alzheimer's)
Darigabat (Epilepsy)...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
- 6669571
Propylnorapomorphine Rotigotine SKF-89,145 SKF-89,626
Stepholidine Tavapadon Tetrahydropalmatine PAMs[clarification needed] Tetrahydroisoquinolines:...
-
emphasis on DA
agonists and
levodopa reformulation.
These include Cerevel's
tavapadon, a D1/D5
receptor partial agonist and UCB0022, a
positive allosteric modulator...
- doxanthrine, fenoldopam, razpipadon, SKF-81,297, SKF-82,958, SKF-89,145,
tavapadon, and trepipam. They have been
researched for and are
under development...
